25 XP   0   0   10

Quantum Genomics SA
Buy, Hold or Sell?

Let's analyse Quantum Genomics SA together

PenkeI guess you are interested in Quantum Genomics SA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Quantum Genomics SA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Quantum Genomics SA

I send you an email if I find something interesting about Quantum Genomics SA.

Quick analysis of Quantum Genomics SA (30 sec.)










What can you expect buying and holding a share of Quantum Genomics SA? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€0.10
Expected worth in 1 year
€-0.60
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
€-0.70
Return On Investment
-651.9%

For what price can you sell your share?

Current Price per Share
€0.11
Expected price per share
€0.1006 - €0.13
How sure are you?
50%

1. Valuation of Quantum Genomics SA (5 min.)




Live pricePrice per Share (EOD)

€0.11

Intrinsic Value Per Share

€-6.87 - €-4.80

Total Value Per Share

€-6.77 - €-4.70

2. Growth of Quantum Genomics SA (5 min.)




Is Quantum Genomics SA growing?

Current yearPrevious yearGrowGrow %
How rich?$3.9m$10.4m-$6.5m-168.0%

How much money is Quantum Genomics SA making?

Current yearPrevious yearGrowGrow %
Making money-$26.9m-$18.7m-$8.1m-30.4%
Net Profit Margin-991.4%-553.2%--

How much money comes from the company's main activities?

3. Financial Health of Quantum Genomics SA (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#783 / 1031

Most Revenue
#410 / 1031

Most Profit
#803 / 1031

Most Efficient
#823 / 1031

What can you expect buying and holding a share of Quantum Genomics SA? (5 min.)

Welcome investor! Quantum Genomics SA's management wants to use your money to grow the business. In return you get a share of Quantum Genomics SA.

What can you expect buying and holding a share of Quantum Genomics SA?

First you should know what it really means to hold a share of Quantum Genomics SA. And how you can make/lose money.

Speculation

The Price per Share of Quantum Genomics SA is €0.1074. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Quantum Genomics SA.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Quantum Genomics SA, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.10. Based on the TTM, the Book Value Change Per Share is €-0.18 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.43 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Quantum Genomics SA.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.77-717.3%-0.77-717.3%-0.52-479.7%-0.46-428.3%-0.30-278.3%
Usd Book Value Change Per Share-0.19-176.3%-0.19-176.3%-0.47-434.2%-0.03-30.6%0.0111.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.19-176.3%-0.19-176.3%-0.47-434.2%-0.03-30.6%0.0111.7%
Usd Price Per Share0.13-0.13-4.64-3.90-4.62-
Price to Earnings Ratio-0.17--0.17--9.00--10.47--28.12-
Price-to-Total Gains Ratio-0.67--0.67--9.94-2.60-24.17-
Price to Book Ratio1.15-1.15-15.41-10.07--140.28-
Price-to-Total Gains Ratio-0.67--0.67--9.94-2.60-24.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.11617458
Number of shares8607
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.19-0.03
Usd Total Gains Per Share-0.19-0.03
Gains per Quarter (8607 shares)-1,629.62-283.32
Gains per Year (8607 shares)-6,518.49-1,133.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-6518-65280-1133-1143
20-13037-130460-2267-2276
30-19555-195640-3400-3409
40-26074-260820-4533-4542
50-32592-326000-5666-5675
60-39111-391180-6800-6808
70-45629-456360-7933-7941
80-52148-521540-9066-9074
90-58666-586720-10199-10207
100-65185-651900-11333-11340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.01.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%5.07.00.041.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.012.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%5.07.00.041.7%

Fundamentals of Quantum Genomics SA

About Quantum Genomics SA

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure. It is developing firibastat, a treatment for high blood pressure, and in combination with others anti-hypertensive drugs. The company also is involved in the development of drugs for the treatment of high blood pressure as monotherapy and the prevention, as well as treatment of heart failure. Quantum Genomics Société Anonyme was incorporated in 2005 and is based in Paris, France.

Fundamental data was last updated by Penke on 2024-03-18 21:51:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Quantum Genomics SA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Quantum Genomics SA earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • A Net Profit Margin of -991.4% means that €-9.91 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Quantum Genomics SA:

  • The MRQ is -991.4%. The company is making a huge loss. -2
  • The TTM is -991.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-991.4%TTM-991.4%0.0%
TTM-991.4%YOY-553.2%-438.3%
TTM-991.4%5Y-614.1%-377.3%
5Y-614.1%10Y-9,305.8%+8,691.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-991.4%-159.2%-832.2%
TTM-991.4%-202.3%-789.1%
YOY-553.2%-263.0%-290.2%
5Y-614.1%-452.4%-161.7%
10Y-9,305.8%-589.0%-8,716.8%
1.1.2. Return on Assets

Shows how efficient Quantum Genomics SA is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • -105.4% Return on Assets means that Quantum Genomics SA generated €-1.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Quantum Genomics SA:

  • The MRQ is -105.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -105.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-105.4%TTM-105.4%0.0%
TTM-105.4%YOY-81.7%-23.7%
TTM-105.4%5Y-73.7%-31.7%
5Y-73.7%10Y-64.5%-9.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-105.4%-12.5%-92.9%
TTM-105.4%-12.2%-93.2%
YOY-81.7%-11.2%-70.5%
5Y-73.7%-13.3%-60.4%
10Y-64.5%-14.6%-49.9%
1.1.3. Return on Equity

Shows how efficient Quantum Genomics SA is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • -691.2% Return on Equity means Quantum Genomics SA generated €-6.91 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Quantum Genomics SA:

  • The MRQ is -691.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -691.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-691.2%TTM-691.2%0.0%
TTM-691.2%YOY-179.6%-511.6%
TTM-691.2%5Y-227.0%-464.2%
5Y-227.0%10Y-133.7%-93.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-691.2%-16.0%-675.2%
TTM-691.2%-15.8%-675.4%
YOY-179.6%-13.9%-165.7%
5Y-227.0%-18.2%-208.8%
10Y-133.7%-19.1%-114.6%

1.2. Operating Efficiency of Quantum Genomics SA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Quantum Genomics SA is operating .

  • Measures how much profit Quantum Genomics SA makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • An Operating Margin of -1,196.1% means the company generated €-11.96  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Quantum Genomics SA:

  • The MRQ is -1,196.1%. The company is operating very inefficient. -2
  • The TTM is -1,196.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,196.1%TTM-1,196.1%0.0%
TTM-1,196.1%YOY-640.9%-555.2%
TTM-1,196.1%5Y-679.1%-517.0%
5Y-679.1%10Y-10,628.3%+9,949.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,196.1%-299.5%-896.6%
TTM-1,196.1%-208.5%-987.6%
YOY-640.9%-280.2%-360.7%
5Y-679.1%-459.9%-219.2%
10Y-10,628.3%-596.9%-10,031.4%
1.2.2. Operating Ratio

Measures how efficient Quantum Genomics SA is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 11.92 means that the operating costs are €11.92 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Quantum Genomics SA:

  • The MRQ is 11.921. The company is inefficient in keeping operating costs low. -1
  • The TTM is 11.921. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ11.921TTM11.9210.000
TTM11.921YOY7.409+4.512
TTM11.9215Y7.384+4.537
5Y7.38410Y125.024-117.640
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.9212.817+9.104
TTM11.9213.181+8.740
YOY7.4093.609+3.800
5Y7.3845.554+1.830
10Y125.0247.396+117.628

1.3. Liquidity of Quantum Genomics SA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Quantum Genomics SA is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.33 means the company has €1.33 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Quantum Genomics SA:

  • The MRQ is 1.330. The company is just able to pay all its short-term debts.
  • The TTM is 1.330. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.330TTM1.3300.000
TTM1.330YOY2.572-1.242
TTM1.3305Y2.980-1.650
5Y2.98010Y3.058-0.078
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3303.987-2.657
TTM1.3304.440-3.110
YOY2.5725.569-2.997
5Y2.9806.158-3.178
10Y3.0586.492-3.434
1.3.2. Quick Ratio

Measures if Quantum Genomics SA is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • A Quick Ratio of 0.59 means the company can pay off €0.59 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Quantum Genomics SA:

  • The MRQ is 0.593. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.593. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.593TTM0.5930.000
TTM0.593YOY2.530-1.936
TTM0.5935Y2.647-2.054
5Y2.64710Y2.921-0.274
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5933.653-3.060
TTM0.5934.158-3.565
YOY2.5305.515-2.985
5Y2.6476.012-3.365
10Y2.9216.206-3.285

1.4. Solvency of Quantum Genomics SA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Quantum Genomics SA assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Quantum Genomics SA to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.85 means that Quantum Genomics SA assets are financed with 84.8% credit (debt) and the remaining percentage (100% - 84.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Quantum Genomics SA:

  • The MRQ is 0.848. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.848. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.848TTM0.8480.000
TTM0.848YOY0.545+0.303
TTM0.8485Y0.462+0.386
5Y0.46210Y0.617-0.156
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8480.336+0.512
TTM0.8480.330+0.518
YOY0.5450.267+0.278
5Y0.4620.367+0.095
10Y0.6170.378+0.239
1.4.2. Debt to Equity Ratio

Measures if Quantum Genomics SA is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • A Debt to Equity ratio of 555.8% means that company has €5.56 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Quantum Genomics SA:

  • The MRQ is 5.558. The company is unable to pay all its debts with equity. -1
  • The TTM is 5.558. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ5.558TTM5.5580.000
TTM5.558YOY1.197+4.360
TTM5.5585Y1.618+3.939
5Y1.61810Y0.935+0.683
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5580.376+5.182
TTM5.5580.398+5.160
YOY1.1970.334+0.863
5Y1.6180.431+1.187
10Y0.9350.476+0.459

2. Market Valuation of Quantum Genomics SA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Quantum Genomics SA generates.

  • Above 15 is considered overpriced but always compare Quantum Genomics SA to the Biotechnology industry mean.
  • A PE ratio of -0.17 means the investor is paying €-0.17 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Quantum Genomics SA:

  • The EOD is -0.151. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.166. Based on the earnings, the company is expensive. -2
  • The TTM is -0.166. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.151MRQ-0.166+0.015
MRQ-0.166TTM-0.1660.000
TTM-0.166YOY-9.000+8.834
TTM-0.1665Y-10.471+10.306
5Y-10.47110Y-28.123+17.651
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.151-2.697+2.546
MRQ-0.166-2.422+2.256
TTM-0.166-2.709+2.543
YOY-9.000-4.116-4.884
5Y-10.471-6.257-4.214
10Y-28.123-6.478-21.645
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Quantum Genomics SA:

  • The EOD is -0.186. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.204. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.204. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.186MRQ-0.204+0.018
MRQ-0.204TTM-0.2040.000
TTM-0.204YOY-8.733+8.528
TTM-0.2045Y-10.164+9.959
5Y-10.16410Y-26.631+16.467
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.186-3.344+3.158
MRQ-0.204-2.939+2.735
TTM-0.204-3.486+3.282
YOY-8.733-5.592-3.141
5Y-10.164-8.464-1.700
10Y-26.631-8.872-17.759
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Quantum Genomics SA is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.15 means the investor is paying €1.15 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Quantum Genomics SA:

  • The EOD is 1.042. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.145. Based on the equity, the company is underpriced. +1
  • The TTM is 1.145. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.042MRQ1.145-0.103
MRQ1.145TTM1.1450.000
TTM1.145YOY15.413-14.268
TTM1.1455Y10.071-8.925
5Y10.07110Y-140.280+150.350
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.0422.198-1.156
MRQ1.1452.042-0.897
TTM1.1452.121-0.976
YOY15.4132.907+12.506
5Y10.0713.682+6.389
10Y-140.2804.114-144.394
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Quantum Genomics SA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.175-0.1750%-0.431+146%-0.030-83%0.012-1602%
Book Value Per Share--0.1030.1030%0.278-63%0.346-70%0.247-58%
Current Ratio--1.3301.3300%2.572-48%2.980-55%3.058-57%
Debt To Asset Ratio--0.8480.8480%0.545+56%0.462+84%0.617+37%
Debt To Equity Ratio--5.5585.5580%1.197+364%1.618+243%0.935+494%
Dividend Per Share----0%-0%-0%-0%
Eps---0.712-0.7120%-0.476-33%-0.425-40%-0.276-61%
Free Cash Flow Per Share---0.577-0.5770%-0.491-15%-0.408-29%-0.265-54%
Free Cash Flow To Equity Per Share---0.086-0.0860%-0.391+357%-0.002-98%0.032-369%
Gross Profit Margin--1.0001.0000%0.188+431%0.710+41%0.855+17%
Intrinsic Value_10Y_max---4.801--------
Intrinsic Value_10Y_min---6.872--------
Intrinsic Value_1Y_max---0.312--------
Intrinsic Value_1Y_min---0.534--------
Intrinsic Value_3Y_max---1.066--------
Intrinsic Value_3Y_min---1.748--------
Intrinsic Value_5Y_max---1.976--------
Intrinsic Value_5Y_min---3.110--------
Market Cap3733621.380-11%4131350.0384131350.0380%148997218.200-97%125322032.448-97%148596882.624-97%
Net Profit Margin---9.914-9.9140%-5.532-44%-6.141-38%-93.058+839%
Operating Margin---11.961-11.9610%-6.409-46%-6.791-43%-106.283+789%
Operating Ratio--11.92111.9210%7.409+61%7.384+61%125.024-90%
Pb Ratio1.042-10%1.1451.1450%15.413-93%10.071-89%-140.280+12350%
Pe Ratio-0.151+9%-0.166-0.1660%-9.000+5332%-10.471+6220%-28.123+16874%
Price Per Share0.107-10%0.1180.1180%4.286-97%3.605-97%4.274-97%
Price To Free Cash Flow Ratio-0.186+9%-0.204-0.2040%-8.733+4172%-10.164+4873%-26.631+12929%
Price To Total Gains Ratio-0.614+9%-0.674-0.6740%-9.942+1375%2.602-126%24.169-103%
Quick Ratio--0.5930.5930%2.530-77%2.647-78%2.921-80%
Return On Assets---1.054-1.0540%-0.817-22%-0.737-30%-0.645-39%
Return On Equity---6.912-6.9120%-1.796-74%-2.270-67%-1.337-81%
Total Gains Per Share---0.175-0.1750%-0.431+146%-0.030-83%0.012-1602%
Usd Book Value--3902352.8193902352.8190%10456793.900-63%13030651.239-70%9290870.466-58%
Usd Book Value Change Per Share---0.189-0.1890%-0.466+146%-0.033-83%0.013-1602%
Usd Book Value Per Share--0.1110.1110%0.301-63%0.375-70%0.267-58%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.770-0.7700%-0.515-33%-0.460-40%-0.299-61%
Usd Free Cash Flow---21864117.613-21864117.6130%-18455965.400-16%-15390370.703-30%-9965781.821-54%
Usd Free Cash Flow Per Share---0.624-0.6240%-0.531-15%-0.442-29%-0.286-54%
Usd Free Cash Flow To Equity Per Share---0.093-0.0930%-0.423+357%-0.002-98%0.034-369%
Usd Market Cap4038658.247-11%4468881.3364468881.3360%161170290.927-97%135560842.499-97%160737247.934-97%
Usd Price Per Share0.116-10%0.1280.1280%4.636-97%3.899-97%4.624-97%
Usd Profit---26972729.268-26972729.2680%-18777230.300-30%-17402445.416-35%-11095576.691-59%
Usd Revenue--2720545.8112720545.8110%3394374.600-20%1953347.922+39%980503.179+177%
Usd Total Gains Per Share---0.189-0.1890%-0.466+146%-0.033-83%0.013-1602%
 EOD+3 -5MRQTTM+0 -0YOY+10 -245Y+4 -3010Y+6 -28

3.2. Fundamental Score

Let's check the fundamental score of Quantum Genomics SA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.151
Price to Book Ratio (EOD)Between0-11.042
Net Profit Margin (MRQ)Greater than0-9.914
Operating Margin (MRQ)Greater than0-11.961
Quick Ratio (MRQ)Greater than10.593
Current Ratio (MRQ)Greater than11.330
Debt to Asset Ratio (MRQ)Less than10.848
Debt to Equity Ratio (MRQ)Less than15.558
Return on Equity (MRQ)Greater than0.15-6.912
Return on Assets (MRQ)Greater than0.05-1.054
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Quantum Genomics SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.029
Ma 20Greater thanMa 500.104
Ma 50Greater thanMa 1000.105
Ma 100Greater thanMa 2000.105
OpenGreater thanClose0.105
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Income Tax Expense  -1,458-89-1,547-519-2,066-425-2,4915,0402,549



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets23,658
Total Liabilities20,050
Total Stockholder Equity3,608
 As reported
Total Liabilities 20,050
Total Stockholder Equity+ 3,608
Total Assets = 23,658

Assets

Total Assets23,658
Total Current Assets23,395
Long-term Assets230
Total Current Assets
Cash And Cash Equivalents 10,401
Short-term Investments 32
Net Receivables 1
Other Current Assets 12,994
Total Current Assets  (as reported)23,395
Total Current Assets  (calculated)23,428
+/- 34
Long-term Assets
Property Plant Equipment 23
Other Assets 34
Long-term Assets  (as reported)230
Long-term Assets  (calculated)57
+/- 173

Liabilities & Shareholders' Equity

Total Current Liabilities17,590
Long-term Liabilities2,416
Total Stockholder Equity3,608
Total Current Liabilities
Short-term Debt 2
Accounts payable 16,008
Other Current Liabilities 1,581
Total Current Liabilities  (as reported)17,590
Total Current Liabilities  (calculated)17,592
+/- 2
Long-term Liabilities
Long term Debt Total 616
Long term Debt 3,034
Capital Lease Obligations Min Short Term Debt-2
Other Liabilities 45
Long-term Liabilities Other 10
Long-term Liabilities  (as reported)2,416
Long-term Liabilities  (calculated)3,702
+/- 1,286
Total Stockholder Equity
Common Stock13,936
Retained Earnings -24,934
Capital Surplus 14,605
Total Stockholder Equity (as reported)3,608
Total Stockholder Equity (calculated)3,608
+/-0
Other
Capital Stock13,936
Cash and Short Term Investments 10,401
Common Stock Shares Outstanding 35,011
Liabilities and Stockholders Equity 23,658
Net Debt -7,367
Net Invested Capital 6,681
Net Tangible Assets 3,608
Net Working Capital 6,431
Property Plant and Equipment Gross 53
Short Long Term Debt Total 3,034



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
> Total Assets 
846
846
850
1,057
1,693
4,753
10,540
14,511
13,917
18,510
14,779
32,802
21,242
23,658
23,65821,24232,80214,77918,51013,91714,51110,5404,7531,6931,057850846846
   > Total Current Assets 
0
0
0
751
1,146
4,129
10,020
13,808
13,476
17,855
14,079
31,829
20,232
23,395
23,39520,23231,82914,07917,85513,47613,80810,0204,1291,146751000
       Cash And Cash Equivalents 
69
139
80
52
334
3,318
4,552
2,198
6,088
14,789
11,164
27,153
13,552
10,401
10,40113,55227,15311,16414,7896,0882,1984,5523,318334528013969
       Short-term Investments 
91
74
39
2
0
0
4,100
9,000
5,002
8
204
285
257
32
3225728520485,0029,0004,100002397491
       Net Receivables 
326
226
385
657
753
644
1,071
1,411
1,614
2,021
-333
4,131
6,091
1
16,0914,131-3332,0211,6141,4111,071644753657385226326
       Inventory 
0
0
0
0
0
0
14
1,011
189
422
333
1,747
1,137
0
01,1371,7473334221891,01114000000
   > Long-term Assets 
0
0
0
306
547
624
520
703
442
655
662
973
1,010
230
2301,010973662655442703520624547306000
       Property Plant Equipment 
26
21
30
23
17
32
54
60
52
53
302
181
442
23
2344218130253526054321723302126
       Goodwill 
0
0
0
0
0
0
0
40
0
0
0
0
0
0
000000400000000
       Long Term Investments 
0
0
0
0
200
146
335
476
258
564
0
0
0
0
00005642584763351462000000
       Intangible Assets 
0
0
0
66
313
429
108
142
91
0
360
760
537
0
053776036009114210842931366000
       Long-term Assets Other 
0
0
0
2
216
162
4,100
9,001
5,004
8
-662
-941
-979
-230
-230-979-941-66285,0049,0014,1001622162000
> Total Liabilities 
835
1,545
1,261
1,975
3,321
4,882
2,518
3,987
5,046
5,612
5,373
8,148
11,575
20,050
20,05011,5758,1485,3735,6125,0463,9872,5184,8823,3211,9751,2611,545835
   > Total Current Liabilities 
350
805
521
1,333
2,624
4,155
1,791
2,716
3,778
5,302
4,324
7,273
7,867
17,590
17,5907,8677,2734,3245,3023,7782,7161,7914,1552,6241,333521805350
       Short-term Debt 
0
0
0
419
1,053
3,308
1
1
1
2
1
385
288
2
2288385121113,3081,053419000
       Short Long Term Debt 
0
0
0
0
1,053
3,308
1
1
1
2
1
2
0
0
002121113,3081,0530000
       Accounts payable 
277
341
382
849
1,223
569
1,400
2,212
3,313
4,732
3,353
5,921
6,746
16,008
16,0086,7465,9213,3534,7323,3132,2121,4005691,223849382341277
       Other Current Liabilities 
74
343
139
65
490
279
78
18
464
568
971
767
708
1,581
1,58170876797156846418782794906513934374
   > Long-term Liabilities 
0
0
0
642
697
727
727
1,271
1,267
311
490
875
3,708
2,416
2,4163,7088754903111,2671,271727727697642000
       Long term Debt Total 
0
0
0
0
0
0
0
1
0
0
0
0
284
616
616284000010000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
2
7
7
3
1
48
10
1048137720000000
       Deferred Long Term Liability 
0
0
0
0
0
326
0
0
0
0
0
0
0
0
0000000032600000
> Total Stockholder Equity
11
0
0
0
-1,628
-130
8,022
10,524
8,871
12,898
9,406
24,654
9,667
3,608
3,6089,66724,6549,40612,8988,87110,5248,022-130-1,62800011
   Retained Earnings -24,934-16,556-11,537-9,078-11,990-26,496-17,114-11,873-8,166-5,959-4,417000
   Accumulated Other Comprehensive Income 0-18,314-14,0180-80-66-50-48-48-41-34000
   Capital Surplus 
0
0
0
0
0
0
0
23,984
30,790
43,951
11,849
27,774
16,913
14,605
14,60516,91327,77411,84943,95130,79023,9840000000
   Treasury Stock00000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2,515
Cost of Revenue-29,502
Gross Profit-26,987-26,987
 
Operating Income (+$)
Gross Profit-26,987
Operating Expense-480
Operating Income-30,083-27,467
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,949
Selling And Marketing Expenses0
Operating Expense4802,949
 
Net Interest Income (+$)
Interest Income22
Interest Expense-18
Other Finance Cost-398
Net Interest Income-394
 
Pretax Income (+$)
Operating Income-30,083
Net Interest Income-394
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-27,485-32,682
EBIT - interestExpense = -30,101
-22,386
-24,918
Interest Expense18
Earnings Before Interest and Taxes (EBIT)-30,083-27,467
Earnings Before Interest and Taxes (EBITDA)-29,819
 
After tax Income (+$)
Income Before Tax-27,485
Tax Provision--2,549
Net Income From Continuing Ops-27,932-24,936
Net Income-24,935
Net Income Applicable To Common Shares-24,936
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses29,982
Total Other Income/Expenses Net2,598394
 

Technical Analysis of Quantum Genomics SA
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Quantum Genomics SA. The general trend of Quantum Genomics SA is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Quantum Genomics SA's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Quantum Genomics SA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.122 < 0.125 < 0.13.

The bearish price targets are: 0.1024 > 0.101 > 0.1006.

Tweet this
Quantum Genomics SA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Quantum Genomics SA. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Quantum Genomics SA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Quantum Genomics SA. The current macd is 0.000025.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Quantum Genomics SA price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Quantum Genomics SA. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Quantum Genomics SA price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Quantum Genomics SA Daily Moving Average Convergence/Divergence (MACD) ChartQuantum Genomics SA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Quantum Genomics SA. The current adx is 60.91.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Quantum Genomics SA shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Quantum Genomics SA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Quantum Genomics SA. The current sar is 0.13409845.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Quantum Genomics SA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Quantum Genomics SA. The current rsi is 55.03. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Quantum Genomics SA Daily Relative Strength Index (RSI) ChartQuantum Genomics SA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Quantum Genomics SA. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Quantum Genomics SA price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Quantum Genomics SA Daily Stochastic Oscillator ChartQuantum Genomics SA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Quantum Genomics SA. The current cci is 48.12.

Quantum Genomics SA Daily Commodity Channel Index (CCI) ChartQuantum Genomics SA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Quantum Genomics SA. The current cmo is 17.62.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Quantum Genomics SA Daily Chande Momentum Oscillator (CMO) ChartQuantum Genomics SA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Quantum Genomics SA. The current willr is -73.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Quantum Genomics SA is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Quantum Genomics SA Daily Williams %R ChartQuantum Genomics SA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Quantum Genomics SA.

Quantum Genomics SA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Quantum Genomics SA. The current atr is 0.0058823.

Quantum Genomics SA Daily Average True Range (ATR) ChartQuantum Genomics SA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Quantum Genomics SA. The current obv is -17,327,681.

Quantum Genomics SA Daily On-Balance Volume (OBV) ChartQuantum Genomics SA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Quantum Genomics SA. The current mfi is 75.53.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Quantum Genomics SA Daily Money Flow Index (MFI) ChartQuantum Genomics SA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Quantum Genomics SA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Quantum Genomics SA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Quantum Genomics SA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5055.029
Ma 20Greater thanMa 500.104
Ma 50Greater thanMa 1000.105
Ma 100Greater thanMa 2000.105
OpenGreater thanClose0.105
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Quantum Genomics SA with someone you think should read this too:
  • Are you bullish or bearish on Quantum Genomics SA? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Quantum Genomics SA? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Quantum Genomics SA

I send you an email if I find something interesting about Quantum Genomics SA.


Comments

How you think about this?

Leave a comment

Stay informed about Quantum Genomics SA.

Receive notifications about Quantum Genomics SA in your mailbox!